Linked Data API

Show Search Form

Search Results

1015562
registered interest false more like this
date less than 2018-11-27more like thismore than 2018-11-27
answering body
Department of Health and Social Care more like this
answering dept id 17 more like this
answering dept short name Health and Social Care remove filter
answering dept sort name Health and Social Care more like this
hansard heading Nusinersen more like this
house id 1 more like this
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Health and Social Care, what discussions his Department has had with NICE on its appraised criteria to facilitate progress towards a Managed Access Arrangement for Spinraza. more like this
tabling member constituency Harborough remove filter
tabling member printed
Neil O'Brien more like this
uin 196306 more like this
answer
answer
is ministerial correction false remove filter
date of answer less than 2018-12-05more like thismore than 2018-12-05
answer text <p>Departmental officials have had a number of discussions with colleagues in the National Institute for Health and Care Excellence (NICE) to enquire about progress of the ongoing appraisal of nusinersen (Spinraza) for the treatment of spinal muscular atrophy. Discussions between NHS England, NICE and Biogen (the company that manufactures nusinersen) are ongoing to seek to agree a commercial agreement that would enable NICE to recommend use of nusinersen as a clinically and cost effective use of National Health Service resources.</p> more like this
answering member constituency Winchester more like this
answering member printed Steve Brine more like this
question first answered
less than 2018-12-05T16:27:43.843Zmore like thismore than 2018-12-05T16:27:43.843Z
answering member
4067
label Biography information for Steve Brine more like this
tabling member
4679
label Biography information for Neil O'Brien more like this